EUVIMEDEUVIMED entdecken
Crossref

Homology modelling and structure-based screening of phenylacetamide derivatives targeting KLK-15 implicated in prostate cancer angiogenesis

Jyothi Bandi, Navaneetha Nambigari

Current Trends in Biotechnology and Pharmacy · 07.04.2026 · 20 (2) · 2913-2934

DOI: 10.5530/ctbp.2026.2.16 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Trends in Biotechnology and Pharmacy, online erschienen am 07.04.2026. Verfasst von Jyothi Bandi und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Bandi, J., & Nambigari, N. (2026). Homology modelling and structure-based screening of phenylacetamide derivatives targeting KLK-15 implicated in prostate cancer angiogenesis. Current Trends in Biotechnology and Pharmacy, 20(2), 2913-2934. https://doi.org/10.5530/ctbp.2026.2.16

Vancouver

Bandi J, Nambigari N. Homology modelling and structure-based screening of phenylacetamide derivatives targeting KLK-15 implicated in prostate cancer angiogenesis. Current Trends in Biotechnology and Pharmacy. 2026;20(2):2913-2934. doi:10.5530/ctbp.2026.2.16

BibTeX
@article{Bandi2026,
  author = {Bandi, Jyothi and Nambigari, Navaneetha},
  title = {Homology modelling and structure-based screening of phenylacetamide derivatives targeting KLK-15 implicated in prostate cancer angiogenesis},
  journal = {Current Trends in Biotechnology and Pharmacy},
  year = {2026},
  volume = {20},
  number = {2},
  pages = {2913--2934},
  doi = {10.5530/ctbp.2026.2.16}
}
Kostenlos starten →